Gyre Therapeutics (GYRE) EBITDA Margin Growth (5y) (2015 - 2026)
Gyre Therapeutics (GYRE) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
148,797.00 |
| Dec 31, 2025 |
90,526.00 |
| Sep 30, 2025 |
182,557.00 |
| Jun 30, 2025 |
105,521.00 |
| Mar 31, 2025 |
4,127.00 |
| Mar 31, 2023 |
11.13 Mn |
| Dec 31, 2022 |
181,089.00 |
| Mar 31, 2022 |
-31,240.00 |
| Dec 31, 2021 |
651,961.00 |
| Sep 30, 2021 |
414,298.00 |
| Jun 30, 2021 |
274,999.00 |
| Mar 31, 2021 |
266,498.00 |
| Dec 31, 2020 |
336,866.00 |
| Sep 30, 2020 |
176,131.00 |
| Jun 30, 2020 |
-54,093.00 |
| Mar 31, 2020 |
97,097.00 |
| Mar 31, 2018 |
-11.11 Mn |
| Dec 31, 2017 |
88,664.00 |
| Sep 30, 2017 |
-84,634.00 |
| Jun 30, 2017 |
-539,793.00 |
